Loteprednol etabonate 5 MG/ML Ophthalmic Suspension — RxCUI 311382
RxNorm drug concept · Semantic clinical drug
RxCUI 311382
Semantic clinical drug · SCD
● Current RxNorm concept 8 FDA products
24 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI311382
Official nameLoteprednol etabonate 5 MG/ML Ophthalmic Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asloteprednol etabonate 0.5 % Ophthalmic Suspension
FDA products mapped8
Package NDCs mapped24
Reported Medicaid activity (SDUD)13,861 prescriptions · 36 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Loteprednol Etabonate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on which product you've been given. Some versions — like Alrex — treat seasonal eye allergies. Eysuvis is used short-term for dry eye disease. Others, like Inveltys and...
- What is loteprednol etabonate actually used for?
- Always wash your hands before touching your eyes or the bottle. Shake the bottle as directed — the shaking instructions are slightly different for each product, so check your label...
- That depends on your condition and which product you're using. For post-surgical use, most products are used for the first two weeks after surgery. Eysuvis for dry eye is approved...
🕸️ Concept Web — How Loteprednol etabonate 5 MG/ML Ophthalmic Suspens... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Loteprednol etabonate 5 MG/ML Ophthalmic Suspension
RxCUI 311382 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Loteprednol etabonate
52177IN
-
Loteprednol etabonate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lotemax
218087BN
-
Lotemax
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Loteprednol etabonate Ophthalmic Suspension
375144SCDF -
Loteprednol etabonate Ophthalmic Product
1163869SCDG -
Loteprednol etabonate Ophthalmic Suspension [Lotemax]
365812SBDF -
Lotemax Ophthalmic Product
1180895SBDG -
Ophthalmic Suspension
316964DF -
Ophthalmic Product
1151135DFG
-
Loteprednol etabonate Ophthalmic Suspension
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Loteprednol etabonate 5 MG/ML
332130SCDC -
Loteprednol etabonate 5 MG/ML Ophthalmic Suspension [Lotemax]
213263SBD -
Loteprednol etabonate 5 MG/ML [Lotemax]
573178SBDC
-
Loteprednol etabonate 5 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Loteprednol etabonate 5 MG/ML
SCDC · 332130 -
Loteprednol etabonate Ophthalmic Suspension
SCDF · 375144 -
Loteprednol etabonate Ophthalmic Product
SCDG · 1163869
Brand-Name Concepts
-
Loteprednol etabonate 5 MG/ML Ophthalmic Suspension [Lotemax]
SBD · 213263 -
Loteprednol etabonate 5 MG/ML [Lotemax]
SBDC · 573178 -
Loteprednol etabonate Ophthalmic Suspension [Lotemax]
SBDF · 365812 -
Lotemax Ophthalmic Product
SBDG · 1180895 -
Lotemax
BN · 218087
📦 FDA Products & Package NDCs
8 products · 24 package NDCs
24 package NDCs map to RxCUI 311382 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00574-4135-05 | 1 BOTTLE, DROPPER in 1 CARTON (0574-4135-05) / 5 mL in 1 BO... | LOTEPREDNOL ETABONATE | Padagis US LLC | 2026-01-12 |
| 00574-4135-10 | 1 BOTTLE, DROPPER in 1 CARTON (0574-4135-10) / 10 mL in 1 B... | LOTEPREDNOL ETABONATE | Padagis US LLC | 2026-01-12 |
| 00574-4135-15 | 1 BOTTLE, DROPPER in 1 CARTON (0574-4135-15) / 15 mL in 1 B... | LOTEPREDNOL ETABONATE | Padagis US LLC | 2026-01-12 |
| 24208-0299-01 | 1 BOTTLE in 1 CARTON (24208-299-01) / 1 mL in 1 BOTTLE | LOTEMAX | Bausch & Lomb Incorporated | 2020-12-15 |
| 24208-0299-05 | 1 BOTTLE in 1 CARTON (24208-299-05) / 5 mL in 1 BOTTLE | LOTEMAX | Bausch & Lomb Incorporated | 1998-09-03 |
| 24208-0299-10 | 1 BOTTLE in 1 CARTON (24208-299-10) / 10 mL in 1 BOTTLE | LOTEMAX | Bausch & Lomb Incorporated | 1998-09-03 |
| 24208-0299-15 | 1 BOTTLE in 1 CARTON (24208-299-15) / 15 mL in 1 BOTTLE | LOTEMAX | Bausch & Lomb Incorporated | 1998-09-03 |
| 60219-1362-01 | 1 BOTTLE in 1 CARTON (60219-1362-1) / 5 mL in 1 BOTTLE | LOTEPREDNOL ETABONATE | Amneal Pharmaceuticals NY LLC | 2025-05-22 |
| 60219-1362-02 | 1 BOTTLE in 1 CARTON (60219-1362-2) / 10 mL in 1 BOTTLE | LOTEPREDNOL ETABONATE | Amneal Pharmaceuticals NY LLC | 2025-05-22 |
| 60219-1362-03 | 1 BOTTLE in 1 CARTON (60219-1362-3) / 15 mL in 1 BOTTLE | LOTEPREDNOL ETABONATE | Amneal Pharmaceuticals NY LLC | 2025-05-22 |
| 62756-0232-55 | 1 BOTTLE in 1 CARTON (62756-232-55) / 10 mL in 1 BOTTLE | Loteprednol Etabonate | Sun Pharmaceutical Industries, Inc. | 2021-05-01 |
| 62756-0232-56 | 1 BOTTLE in 1 CARTON (62756-232-56) / 15 mL in 1 BOTTLE | Loteprednol Etabonate | Sun Pharmaceutical Industries, Inc. | 2021-05-01 |
| 62756-0232-90 | 1 BOTTLE in 1 CARTON (62756-232-90) / 5 mL in 1 BOTTLE | Loteprednol Etabonate | Sun Pharmaceutical Industries, Inc. | 2021-05-01 |
| 70244-0034-01 | 1 BOTTLE, DROPPER in 1 CARTON (70244-034-01) / 5 mL in 1 BO... | Loteprednol Etabonate | Sentiss Pharmaceuticals LLC | 2026-04-17 |
| 70244-0034-02 | 1 BOTTLE, DROPPER in 1 CARTON (70244-034-02) / 10 mL in 1 B... | Loteprednol Etabonate | Sentiss Pharmaceuticals LLC | 2026-04-17 |
| 70244-0034-03 | 1 BOTTLE, DROPPER in 1 CARTON (70244-034-03) / 15 mL in 1 B... | Loteprednol Etabonate | Sentiss Pharmaceuticals LLC | 2026-04-17 |
| 70748-0300-01 | 1 BOTTLE in 1 CARTON (70748-300-01) / 5 mL in 1 BOTTLE | loteprednol etabonate | Lupin Pharmaceuticals, Inc. | 2025-07-15 |
| 70748-0300-02 | 1 BOTTLE in 1 CARTON (70748-300-02) / 10 mL in 1 BOTTLE | loteprednol etabonate | Lupin Pharmaceuticals, Inc. | 2025-08-27 |
| 72485-0665-05 | 1 BOTTLE, DROPPER in 1 CARTON (72485-665-05) / 5 mL in 1 BO... | Loteprednol Etabonate | ARMAS PHARMACEUTICALS INC. | 2023-10-26 |
| 72485-0665-10 | 1 BOTTLE, DROPPER in 1 CARTON (72485-665-10) / 10 mL in 1 B... | Loteprednol Etabonate | ARMAS PHARMACEUTICALS INC. | 2023-10-26 |
| 72485-0665-15 | 1 BOTTLE, DROPPER in 1 CARTON (72485-665-15) / 15 mL in 1 B... | Loteprednol Etabonate | ARMAS PHARMACEUTICALS INC. | 2023-10-26 |
| 82260-0299-05 | 1 BOTTLE in 1 CARTON (82260-299-05) / 5 mL in 1 BOTTLE | Loteprednol Etabonate | Bausch & Lomb Americas Inc. | 2023-04-07 |
| 82260-0299-10 | 1 BOTTLE in 1 CARTON (82260-299-10) / 10 mL in 1 BOTTLE | Loteprednol Etabonate | Bausch & Lomb Americas Inc. | 2023-04-07 |
| 82260-0299-15 | 1 BOTTLE in 1 CARTON (82260-299-15) / 15 mL in 1 BOTTLE | Loteprednol Etabonate | Bausch & Lomb Americas Inc. | 2023-04-07 |
Observed labelers:
Bausch & Lomb Incorporated (4) ·
Amneal Pharmaceuticals NY LLC (3) ·
ARMAS PHARMACEUTICALS INC. (3) ·
Bausch & Lomb Americas Inc. (3) ·
Padagis US LLC (3) ·
Sentiss Pharmaceuticals LLC (3)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.